Our understanding of estrogen signaling in the nervous system has undergone a significant shift in recent years. For over three decades, the idea that all estradiol actions were explained by direct regulation of transcription held sway. Within the past decade, the idea that in addition to classical effects, membrane-initiated actions of estradiol are important has gained traction. While several novel putative membrane estrogen receptors (ERs) have been described, a large fraction of measured responses appear to be due to membrane-localized estrogen receptor-α (ERa) and estrogen receptor-ß (ERß), the same proteins that regulate gene expression. These membrane-localized ERs participate in the regulation of the synthesis of neuroprogesterone, dorsal root ganglion (DRG) neuron excitation, and female sexual receptivity. This is achieved by the modulation of intracellular cell signaling pathways usually associated with the activation of G protein-coupled receptors (GPCRs ERß with metabotropic glutamate receptors (mGluRs), allowing estradiol to signal through mGluRs. This ER/mGIuR hypothesis explains how estradiol can activate a wide-range of intracellular pathways and provides an underlying mechanism for the hitherto seemingly unrelated rapid membrane actions in the nervous system.
INTRODUCTION
The importance of steroid hormones in the regulation of nervous system function cannot be overstated. Estrogens, in particular, have profound effects on a variety of neurological systems. The most obvious actions include those that are related to sexual differentiation of the brain /19/ and the central control of reproduction /48/. More recently, estradiol has been shown to be critical in a number of cellular events, such as neuronal growth and restructuring, that impact cognition, long-term potentiation, neuroprotection and mood /4,32,67/. While the impact of estrogens on these behaviors has been well characterized, the underlying mechanism^) through which the steroid acts to affect many of these processes remains to be elucidated. It was once accepted that the only mechanism of estrogen action was through the binding of intracellular receptors that act as transcription factors. An important finding that has enhanced our understanding of estradiol action was the realization that estradiol can also act on estrogen receptors (ERs) localized at the cell membrane surface. This is in distinction to the classical actions of estrogens, VOLUME 19 , NO. 6, 2008 which typically have long time courses and involve gene transcription and protein translation. Classic actions are mediated by estrogen receptor-α (ERa) and estrogen receptor-ß (ERß). Upon steroid binding, these receptors dimerize, allowing them to functionally interact with specific parts of the genome known as estrogen response elements (EREs) to regulate gene expression. Activated estrogen receptors can also regulate transcription through the stabilization of other DNA binding proteins such as those that interact with activator protein 1 (AP-1) /31,45,78/.
MEMBRANE-INITIATED MECHANISMS OF ESTROGEN ACTION
For many years, the principal defining feature of a non-classical or novel effect of estradiol acting at the membrane surface was the rapid response. This criterion dates back to the initial observation of estradiol-induced accumulation of cAMP in uterine tissue by Szego and Davis /69/. A similar time course of effects was noted in neurons by Moss and Kelly who showed that estradiol affected the electrical activity of preoptic and septal neurons within seconds 1251. The effects of membrane estrogen signaling can be observed within seconds, but this does not preclude more sustained action. Transmission of information from the membrane surface to the nucleus also occurs following the rapid signaling of estrogens, as illustrated by its ability to activate transcription factors such as cAMP response element binding protein (CREB) /6,22,70,76/. In addition to the time course of onset, several other hallmarks of estradiol action on the membrane have been described. Membrane estradiol signaling is typically: i) blocked by ER antagonists; ii) activated by agonists /6,8/; and iii) mimicked by membrane impermeable estrogen conjugates /55,80/. Importantly, these rapid actions cannot be induced by intracellular dialysis of neurons with estradiol /37/. In 1999, overexpression of ERa and ERß revealed that a portion of the classic ER proteins was targeted to the membrane and activated intracellular signaling /58/. This simple and elegant experiment demonstrated that the same proteins can mediate both intracellular and membrane actions of estradiol. Two other putative membrane ERs have been described: ER-X /72/, and an estrogen-responsive GPCR that is activated by the drug STX 1521. ER-X, which appears to be preferentially activated by 17a-estradiol (as opposed to the gonadally-derived 17ß isoform /73/), is functionally coupled to MAPK signaling ΙΊ2Ι. In the cortex, ER-X is expressed during development, but can be upregulated following tissue injury. To date, the amino acid composition of ER-X has yet to be determined, although based on its cross reactivity with ERa antibodies, it is of similar size and composition to this classical ER. The effects of STX, which shares structural features with estradiol, have been observed in hypothalamic neurons and linked to regulation of homeostasis /52,53/. As with ER-X, the molecular composition of this estrogen binding protein is currently unknown, but it has been hypothesized that the STX-activated protein is a GPCR, since downstream effects are sensitive to G protein modulation.
While little doubt remains regarding the existence of membrane ERa or ERß and that the consequences of their activation can be observed both in vitro and in vivo, their specific roles in the nervous system have remained somewhat difficult to place in a physiological context. This review concentrates on several physiological events in which rapid, membrane-initiated estradiol signaling requires ERa or ERß. Specifically, we focus on the synthesis of neuroprogesterone involved in positive feedback of the luteinizing hormone (LH) surge, the modulation of putative nociceptive signaling in dorsal root ganglion (DRG) neurons and the control of sexual receptivity. We conclude by providing a model, delineated in hippocampal tissue, which explains the proximal signaling of membrane ERa or ERß. In these systems, we have found that membrane-associated ERa and ERß rely upon metabotropic glutamate receptors (mGluRs) in order to activate cell signaling events 161.
NEUROPROGESTERONE SYNTHESIS
Circulating estradiol regulates the hypothalamic-pituitary-gonadal (HPG) axis through negative and positive feedback mechanisms. Estrogen positive feedback that is responsible for the LH surge depends on high physiological concentrations of estradiol that stimulate both the expression of progesterone receptors as well as progesterone synthesis in the brain (i.e. neuroprogesterone) (reviewed in /40/). Estradiol facilitates neuroprogesteone synthesis in astrocytes /40/. The mechanism of neuroprogesterone synthesis in adult hypothalamic astrocytes involves estradiol-induced release of calcium from intracellular stores /1.0/. This calcium flux is dependent on activation of the phospholipase C/inositol trisphosphate (PLC/IP3) pathway, and is blocked by inhibiting the IP3 receptor /10/. Calcium flux in astrocytes is stereospecific, activated by 17ß-estradiol and not 17a-estradiol. It is also dependent on membrane ERs, as constrained estradiol coupled to bovine serum albumin (E-6-BSA) mimicked free estradiol action. Furthermore, thapsigargin release of IP3-sensitve calcium stores stimulates neuroprogesterone synthesis in the absence of estradiol. This increase in neuroprogesterone synthesis in the hypothalamus on the afternoon of proestrus is necessary for the estradiol-induced LH surge, the event underlying ovulation 139/. According to this model, as circulating levels of estradiol from the ovary rise, they initially induce the transcription of progesterone receptors in neurons. When estradiol levels peak in proestrus, they stimulate the synthesis of neuroprogesterone in astrocytes. The locally produced neuroprogesterone then activates progesterone receptors permitting the sensory, metabolic and circadian inputs to stimulate a network that induces a surge release of gonadotropin-releasing hormone (GnRH), then in turn LH, inducing ovulation.
ATP SIGNALING IN DRG NEURONS
Estradiol also rapidly modulates cell signaling in primary afferent sensory neurons whose cell bodies are located in DRGs. DRG neurons transmit information about chemical or mechanical stimulation from the periphery to the spinal cord. ATP is a putative signal for visceral pain and is released by distention of the viscera and tissue damage 191. ATP transmits noxious stimuli by activating purinergic, ATP-gated P2X receptors on primary afferent fibers /14/. The opening of P2X channels results in membrane depolarization sufficient to trigger action potentials and calcium influx through voltage-gated calcium channels (VGCCs) associated with nociception 1211.
In primary DRG cultures, the ATP-mediated calcium flux was inhibited by estradiol in 85% of the small neurons. Estradiol action was stereospecific, and inhibited by ER antagonists tamoxifen and ICI 182,780. The cellular calcium response initiated by ATP has two components: the initial ion flux is through activated P2X channels, and the secondary response is the opening of VGCCs in response to membrane depolarization 1211. The entire free cytoplasmic calcium ( 
SEXUAL RECEPTIVITY
In the female rat, estradiol acts on a limbichypothalamic circuit that changes the salience of information about the environment (and cutaneous sensory input) to permit the expression of the stereotypic sexually receptive behavior, the lordosis reflex /41,65/. In intact rodents, the rising levels of estradiol, which stimulate the lordosis regulating circuit, are facilitated by progesterone to achieve maximal sexual receptivity. To a first approximation, estradiol induction of female sexually receptive behavior has a time course that strongly implicates transcriptional actions. Indeed, studies over the years /20,56/ have demonstrated that estradiol initiation of lordosis behavior requires transcription and translation of new proteins. With the advent of immunohistochemistry, radioimmunoassay and in situ hybridization, it was shown that reproductively relevant neuropeptide levels were increased by estradiol (e.g., /3,12,42,49, 50,62,79/). Endogenous opioid peptides are among the best studied mediators of lordosis-regulating circuits in the central nervous system (CNS). One of these endogenous opioids is ß-endorphin (ß-END) that participates in an arcuate nucleus to medial preoptic nucleus projection that regulates lordosis behavior /43/. A signature of estradiol activation of this circuit is the rapid internalization of μ-opioid receptors (MORs) in the medial preoptic nucleus. MOR internalization is tightly correlated with the display of lordosis behavior /15, 66,74/. While the effects of estradiol on MOR internalization can be observed within minutes of steroid treatment, it is in fact critically important for the display of lordosis 30-48 hours later. This finding strongly suggests that rapid estradiol signaling is also important for the central control of lordosis /64/. Moreover, the effect of estradiol on MOR internalization is mimicked by a membraneconstrained estradiol conjugate (i.e. E-6-biotin) injected directly into the arcuate nucleus, implying a membrane-initiated estrogen signaling mechanism within this brain region. The putative role of membrane-initiated estrogen signaling was directly demonstrated by systemically injecting rats with another membrane-constrained conjugate E-6-BSA followed by a systemic injection of free estradiol. E-6-BSA was found to augment the response to free estradiol /28/. Thus it appears membraneinitiated, rapid estradiol signaling facilitates nuclear ER-stimulated transcriptional events, suggesting cooperation between the nuclear-and membraneinitiated actions of estradiol.
ER SIGNALING THROUGH mGluRs
In each of the three physiological systems described, the response to estradiol was rapid and mediated by membrane ERa and/or ERß, established hallmarks for membrane-initiated signaling. What was not immediately clear was how classical ERs, known to be transcription factors, with a structure that does not resemble membrane receptors, initiate cell signaling. Initially, membranemediated estradiol actions were seen to affect G protein-dependent cell signaling pathways, suggesting that membrane ERs were a GPCR /34,75/. However, this hypothesis does not explain how ERa or ERß can initiate G protein signaling. We have recently provided an alternative explanation to the 'ER as GPCR' hypothesis. It is our working theory that ERs activate mGluRs through a direct protein-protein interaction. Upon estradiol binding to the ER, the ER promotes transactivation of the mGluR, initiating mGluR signaling without the requirement of glutamate. In effect, the ER alters the confirmation of the mGluR, resulting in activation of the downstream G proteins and initiating second messenger signaling. This hypothesis is partially based on previous precedent, as in non-neuronal tissue, ERs have been found to directly bind tyrosine kinase receptors /68/, which are in turn activated following estrogen application /24/. This common mechanism of ERs activating surface receptors may account for the novel actions of estradiol outside the brain, as mGluR expression is nervous system specific. Notably, this does not preclude the converse possibility, i.e. that ERs interact with tyrosine kinase receptors in the CNS as well. Indeed, these interactions occur in the hypothalamus to influence reproduction /16/ as well as in the substantia nigra where it appears to mediate neuroprotection /54/. In terms of evidence for this putative mechanism, co-immunoprecipitation experiments suggest that ERs can directly interact with mGluRs /13/ (Fig. 1A) . Experiments utilizing an mGluR agonist and an ER antagonist strongly suggest this putative protein-protein interaction can alter the function of mGluR signaling. Figure IB examines CREB phosphorylation following activation of mGluR 1 with DHPG, a selective mGluR la agonist. Activation of CREB by DHPG is attenuated following application of the ER antagonist, ICI 182,780. This action of ICI 182,780 does not appear due to a direct effect on mGluR 1, as in cultures from male animals, which lack an estrogen response; ICI 182,780 does not influence the actions of DHPG (Fig. 1C) . Future research is needed to more definitively determine whether this hypothesis of ER-to-mGluR signaling is accurate.
In hippocampal neurons, estradiol activation of ERs can lead to the phosphorylation of CREB via stimulation of both group I (Gq-coupled) and group II (Gi/o-coupled) mGluRs 161. This action of estradiol in hippocampal tissue was only found in neurons generated from female and not male tissue. In a follow-up study, we determined ER interactions with mGluRs tö be dependent upon caveolin proteins /5/, known to be essential for the trafficking and clustering of signaling molecules. The importance of caveolin proteins in the trafficking of ERa to the membrane was first demonstrated outside the nervous system /57/, and palmitoylation of the ER was also required /2,47/.
ER interactions with caveolins and mGluRs are not random. In hippocampal neurons, ERa interaction with either mGluR 1 or mGluR2/3 was dependent upon caveolin 1 (CAV1) or caveolin 3 (CAV3), respectively. Conversely, ERß only interacted with mGluR2/3 via CAV3. The pairing of particular ERs with mGluRs is observed in various other brain regions (Fig. 2) /13/. In striatal neurons, we have found that ERa via CAV1 activates mGluR5 /21/. This is of particular interest because striatal neurons express both group I mGluRs, mGluR 1 and mGluR5. In striatal neurons, mGluR 1 signaling was unaffected by estradiol. It remains to be determined why, across different neuronal populations, ERs would be paired with discrete types of mGluRs that are known to activate the same second messenger systems.
Functional isolation of different ERs with mGluRs suggests a diverse array of potential estrogen-sensitive signaling pathways at the disposal of individual cells (Fig. 2) . The generation of specific ER/mGluR pairs via caveolin function may eventually be found to be responsible for many of the diverse observations of novel estrogen signaling in the CNS.
THE PHYSIOLOGY OF MEMBRANE ESTROGEN RECEPTORS CAN BE EXPLAINED BY INTERACTION WITH mGluRs
Each of the rapid estradiol actions -neuroprogesterone synthesis, attenuation of ATP signaling in DRG neurons and sexual receptivity -are dependent on membrane ERs interacting with mGluR Is. In hypothalamic astrocyte cultures, in which estradiol stimulated calcium flux and neuroprogesterone synthesis, blocking mGluR la with the selective antagonist, LY367385, prevented the estradiol-induced calcium flux /29/. Further evidence of such an interaction is the co-immunoprecipitation of ERa and mGluR la in the membrane fraction of astrocytes. Interestingly, separate activation by estradiol or DHPG, a selective mGluRla agonist, produced robust calcium flux, but alone neither were as effective at stimulating calcium flux as they are together, indicating that for maximal signaling in astrocytes both glutamate and estradiol need to be present. These results suggest that estradiol may act most effectively on astrocytes that are in proximity to active glutamatergic terminals (Fig. 3) . attenuates CREB phosphorylation following application of the group I mGluR agonist DHPG. C. ICI 182,780 has no effect on CREB phosphorylation in cultures generated from male tissue, which lack the mGluR-mediated estrogen response (from /38/).
As predicted by the ER/mGluR hypothesis, estradiol stimulation of mGluR2/3 should block calcium flux through L-type VGCC 161. In DRG neurons, membrane ERa attenuated the ATPinduced calcium flux, suggesting that ERa interacts, in a tissue-specific manner, with mGluR2/3 /5,6/. To test this possibility, DRG neurons were treated with estradiol or estradiol + LY341495, an mGluR2/3 inhibitor, before ATP stimulation to induce a calcium flux /35/. As predicted, estradiol attenuated ATP-induced calcium flux, an effect blocked by LY341495. Thus, the estradiol action on DRG neurons requires the interaction of ERa with mGluR2/3.
As with estrogen effects on neuroprogesterone synthesis and ATP signaling in DRG neurons, the rapid estradiol effect on MOR internalization is blocked following antagonism of the mGluRla in the arcuate nucleus. Moreover, estradiol-induced lordosis is attenuated, but only if the mGluRla is antagonized at the time of estradiol treatment, and not several hours after estradiol, further suggesting that mGluR 1 signaling is directly related to the rapid action of estradiol. Our understanding of how the ER/mGluR interaction mediates behavior is illustrated in Figure 4 . Low systemic estradiol levels are insufficient to elicit lordosis behavior. The arcuate-medial preoptic circuit is quiescent. Membrane ERs in the arcuate nucleus are not stimulated, which is reflected by the cellular distribution of MORs in the medial preoptic area. The majority of MORs are localized on the cell membrane, indicating that these receptors have not been activated. In these conditions, the female rat is not sexually receptive (Fig. 4A) . However, when systemic estradiol levels reach levels that induce lordosis behavior, membrane ERs in the arcuate nucleus are activated, leading to MOR internalization and subsequent full lordosis behavior (Fig.  4B) . Accordingly, when mGluRla is directly stimulated with an agonist under low estradiol conditions, membrane ERs can be bypassed, resulting in MOR internalization and facilitation of lordosis (Fig. 4C) . Conversely, under high estrogenic conditions antagonizing mGluRla blocks estrogen-induced MOR internalization and attenuates sexual behavior (Fig. 4D ). These data are consistent with the in vitro demonstration of ERa/mGluRla signaling in hippocampal neurons, and provided the first in vivo evidence that estradiol can signal through activation of mGluRla By demonstrating that lordosis behavior, a classical assay of estradiol action, has a rapid non-genomic component underscores the importance of ER/ mGluR interactions in the brain /13/.
CONCLUSIONS
Clearly, we are in the initial stages of understanding when and how rapid estradiol actions fit into the physiological context of estradiol signaling in the nervous system. Recent findings suggest a mechanism by which ERs in the membrane can elicit changes in cell signaling, and several different systems in which the actions of estradiol on membrane ERs require an interaction with mGluRs. This mechanism of, ER-mGluR interactions provides a framework through which the pleomorphic membrane-initiated estradiol actions can be understood and used to elucidate various means by which ERs play an important role in brain function.
